CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 30 enrolled
Drug / intervention
Vapotherm +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00934128
NCT00934128Phase 2Completed
CompareCT.gov

An Exploratory Trial of Bilevel Positive Airway Pressure Device and High Flow Oxygen for Persistent Dyspnea in Advanced Cancer Patients

M.D. Anderson Cancer Center·interventional·Posted Jul 8, 2009·Updated Mar 2, 2016

In Brief

A Phase 2 clinical trial evaluating Vapotherm and BIPAP for Advanced Cancers. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The goal of this clinical research study is to learn if specialized breathing devices reduce the sensation of shortness of breath in patients with advanced cancer who are experiencing shortness of breath. Researchers want to learn if these devices can help to control shortness of breath. The 2 devices being tested and compared are called BiPAP (bilevel positive airway pressure) and Vapotherm.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdvanced Cancers
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 8, 2009
Enrollment StartAug 1, 2009
Primary CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 17.0 years ago

Interventions

Vapothermdevice

Deliver air in and out of the lungs, warmed, filtered for bacteria, and then delivered through the nose using a tube under the nostrils.

BIPAPdevice

Air given through a mask, and amount can be set to different levels allowing more air in and out of lungs without using as much effort as regular breathing.